RESFLU-S-250 | Fluticasone Propionate & Salmeterol Inhaler IP – PCD Franchise in India
RESFLU-S-250 INHALER is a combination inhaler formulated to provide comprehensive relief from the symptoms of asthma and chronic obstructive pulmonary disease (COPD). This advanced inhaler combines Fluticasone Propionate, a potent anti-inflammatory corticosteroid, with Salmeterol, a long-acting beta-agonist (LABA), to reduce airway inflammation and promote smooth, easy breathing, making it a trusted choice for long-term asthma and COPD management.
Composition:
- Fluticasone Propionate 250 mcg: A corticosteroid that works by reducing inflammation in the airways, preventing asthma attacks and managing symptoms of COPD.
- Salmeterol 50 mcg: A long-acting beta-agonist that helps relax the muscles of the airways, improving airflow and reducing wheezing and shortness of breath.
Packing:
- 7.2 gm Inhaler – Contains 120 metered doses, ensuring long-lasting and reliable treatment.
Key Features of RESFLU-S-250 INHALER
- Dual-Action Therapy: Combines the anti-inflammatory power of Fluticasone Propionate with the bronchodilatory effect of Salmeterol, providing comprehensive and effective treatment.
- Long-Lasting Relief: Provides up to 12 hours of bronchodilation with each use, making it ideal for managing both asthma and COPD symptoms throughout the day.
- Precise Dosing: The metered-dose inhaler ensures consistent and accurate medication delivery with every puff.
Indications:
- Long-term management of asthma in patients 12 years and older.
- Management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
- Prevention of exercise-induced bronchospasm for patients with asthma.
Benefits of RESFLU-S-250 INHALER
- Effective Combination: Works on both the inflammation and constriction of the airways for complete asthma and COPD management.
- Extended Relief: Salmeterol helps keep airways open for up to 12 hours, reducing the need for frequent dosing.
- Improved Quality of Life: Helps reduce the frequency and severity of asthma attacks, making it easier to breathe and engage in daily activities.